EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY

  Back
EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/02bf1a2a931afc9ce52e182f1b3ee406.pdf
Carla
Nester
12
Richard Smith richard-smith@uiowa.edu Carver College of Medicine, University of Iowa Nephrology lowa city United States
David Kavanagh david.kavanagh@newcastle.ac.uk Newcastle University Nephrology Newcastle upon Tyne United Kingdom
Marina Vivarelli marina.vivarelli@opbg.net Bambino Gesù Children's Hospital, IRCCS Nephrology Rome Italy
Giuseppe Remuzzi giuseppe.remuzzi@marionegri.it Istituto di Ricerche Farmacologiche Mario Negri IRCCS Nephrology Bergamo Italy
Ming-Hui Zhao mhzhao@bjmu.edu.cn Peking University First Hospital Nephrology Beijing China
Edwin Wong Edwin.wong1@nhs.net Newcastle University Nephrology Newcastle upon Tyne United Kingdom
Yaqin Wang yaqin.wang@novartis.com Novartis Pharmaceuticals Corporation Nephrology East Hanover United States
Angelo Trapani angelo.trapani@novartis.com Novartis Pharmaceuticals Corporation Nephrology East Hanover United States
Induja Krishnan induja.krishnan@novartis.com Novartis Pharmaceuticals Corporation Nephrology East Hanover United States
Nicholas Webb nicholas.webb@novartis.com Novartis Pharma AG Nephrology Basel Switzerland
Matthias Meier matthias.meier@novartis.com Novartis Pharma AG Nephrology Basel Switzerland
Andrew Bomback asb68@cumc.columbia.edu Columbia University College of Physicians and Surgeons Nephrology New York United States